Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis - PubMed (original) (raw)
. 1994 Nov;145(5):1237-45.
Affiliations
- PMID: 7977654
- PMCID: PMC1887434
Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis
T H Mauad et al. Am J Pathol. 1994 Nov.
Abstract
The mouse mdr2 gene (and its human homologue MDR3, also called MDR2) encodes a P-glycoprotein that is present in high concentration in the bile canalicular membrane of hepatocytes. The 129/OlaHsd mice with a homozygous disruption of the mdr2 gene (-/- mice) lack this P-glycoprotein in the canalicular membrane. These mice are unable to secrete phospholipids into bile, showing an essential role for the mdr2 P-glycoprotein in the transport of phosphatidylcholine across the canalicular membrane. The complete absence of phospholipids from bile leads to a hepatic disease, which becomes manifest shortly after birth and shows progression to an end stage in the course of 3 months. The liver pathology is that of a nonsuppurative inflammatory cholangitis with portal inflammation and ductular proliferation, consistent with toxic injury of the biliary system from bile salts unaccompanied by phospholipids. Thus, the mdr2 (-/-) mice can serve as an animal model for studying mechanisms and potential interventions in nonsuppurative inflammatory cholangitis (in a generic sense) in human disease, be it congenital or acquired. When the mice are 4 to 6 months of age, preneoplastic lesions develop in the liver, progressing to metastatic liver cancer in the terminal phase. The mdr2 (-/-) mice therefore also provide a tumor progression model of value for the study of hepatic carcinogenesis. Interestingly, also in this regard, the model mimicks human disease, because chronic inflammation of the biliary system in humans may similarly carry increased cancer risk.
Similar articles
- Hepatocyte-specific expression of the human MDR3 P-glycoprotein gene restores the biliary phosphatidylcholine excretion absent in Mdr2 (-/-) mice.
Smith AJ, de Vree JM, Ottenhoff R, Oude Elferink RP, Schinkel AH, Borst P. Smith AJ, et al. Hepatology. 1998 Aug;28(2):530-6. doi: 10.1002/hep.510280234. Hepatology. 1998. PMID: 9696021 - Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse.
Oude Elferink RP, Ottenhoff R, van Wijland M, Smit JJ, Schinkel AH, Groen AK. Oude Elferink RP, et al. J Clin Invest. 1995 Jan;95(1):31-8. doi: 10.1172/JCI117658. J Clin Invest. 1995. PMID: 7814632 Free PMC article. - Multiple adaptive mechanisms to chronic liver disease revealed at early stages of liver carcinogenesis in the Mdr2-knockout mice.
Katzenellenbogen M, Pappo O, Barash H, Klopstock N, Mizrahi L, Olam D, Jacob-Hirsch J, Amariglio N, Rechavi G, Mitchell LA, Kohen R, Domany E, Galun E, Goldenberg D. Katzenellenbogen M, et al. Cancer Res. 2006 Apr 15;66(8):4001-10. doi: 10.1158/0008-5472.CAN-05-2937. Cancer Res. 2006. PMID: 16618719 - Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
Maggiore G, Riva S, Sciveres M. Maggiore G, et al. Minerva Gastroenterol Dietol. 2009 Mar;55(1):53-70. Minerva Gastroenterol Dietol. 2009. PMID: 19212308 Review. - Influence of bile salts on hepatic mdr2 P-glycoprotein expression.
Frijters CM, Ottenhoff R, Van Wijland MJ, Van Nieuwkerk C, Groen AK, Oude Elferink RP. Frijters CM, et al. Adv Enzyme Regul. 1996;36:351-63. doi: 10.1016/0065-2571(95)00019-4. Adv Enzyme Regul. 1996. PMID: 8869755 Review.
Cited by
- Inflammation-Related Carcinogenesis: Lessons from Animal Models to Clinical Aspects.
Okada F, Izutsu R, Goto K, Osaki M. Okada F, et al. Cancers (Basel). 2021 Feb 22;13(4):921. doi: 10.3390/cancers13040921. Cancers (Basel). 2021. PMID: 33671768 Free PMC article. Review. - Evaluation of 11C-acetate and 18F-FDG PET/CT in mouse multidrug resistance gene-2 deficient mouse model of hepatocellular carcinoma.
Territo PR, Maluccio M, Riley AA, McCarthy BP, Fletcher J, Tann M, Saxena R, Skill NJ. Territo PR, et al. BMC Med Imaging. 2015 May 16;15:15. doi: 10.1186/s12880-015-0058-z. BMC Med Imaging. 2015. PMID: 25981587 Free PMC article. - Steatohepatitis in laboratory opossums exhibiting a high lipemic response to dietary cholesterol and fat.
Chan J, Sharkey FE, Kushwaha RS, VandeBerg JF, VandeBerg JL. Chan J, et al. Am J Physiol Gastrointest Liver Physiol. 2012 Jul;303(1):G12-9. doi: 10.1152/ajpgi.00415.2011. Epub 2012 May 3. Am J Physiol Gastrointest Liver Physiol. 2012. PMID: 22556142 Free PMC article. - Intersecting pathways in inflammation and cancer: Hepatocellular carcinoma as a paradigm.
Wai PY, Kuo PC. Wai PY, et al. World J Clin Oncol. 2012 Feb 10;3(2):15-23. doi: 10.5306/wjco.v3.i2.15. World J Clin Oncol. 2012. PMID: 22347691 Free PMC article. - Transcript profiling identifies iqgap2(-/-) mouse as a model for advanced human hepatocellular carcinoma.
Gnatenko DV, Xu X, Zhu W, Schmidt VA. Gnatenko DV, et al. PLoS One. 2013 Aug 12;8(8):e71826. doi: 10.1371/journal.pone.0071826. eCollection 2013. PLoS One. 2013. PMID: 23951254 Free PMC article.
References
- Acta Paediatr Scand. 1986 Nov;75(6):1010-6 - PubMed
- Gut. 1994 Feb;35(2):260-5 - PubMed
- Proc Natl Acad Sci U S A. 1987 May;84(9):3004-8 - PubMed
- Arch Toxicol Suppl. 1987;10:29-42 - PubMed
- Arch Toxicol Suppl. 1987;10:81-94 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases